Avirax Pharmaceuticals PLC began producing Active Pharmaceutical Ingredients (APIs) in 1995, recognizing their crucial role in the manufacture of complex formulations and enabling vertical integration. Today, we offer an extensive portfolio of over 380 APIs, which are used both in-house and marketed to customers in more than 60 countries.

Our 14 manufacturing facilities across key global locations, including India, Hungary, the US, Israel, and Australia, produce a diverse range of APIs. Our product portfolio includes both generics and complex APIs, which require specialized manufacturing areas, including those for:

• Anti-cancers
• Peptides
• Steroids
• Sex hormones
• Controlled substances, such as poppy-derived opiate raw materials used primarily in the production of analgesics (sold as both Narcotic Raw Materials (NRM) and APIs)

In addition to bulk active ingredients, we also offer intermediates and custom synthesis services, tailored to meet the specific needs of our partners and customers worldwide.